Cormedix Inc (CRMD)

$5.18 0.23 (4.25%)

13:13 EDT CRMD Stock Quote Delayed 30 Minutes

CRMD Stock Earnings: Cormedix Beats EPS for Q1 2024

By InvestorPlace Earnings May 9, 2024

CRMD stock results show that Cormedix beat analyst estimates for earnings per share the first quarter of 2024.

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Why Is Cormedix (CRMD) Stock Down 23% Today?

More Articles

Volume:

Previous Close -

Market Cap 197.29M

PE Ratio -5.57

EPS -0.93

Volume (Avg. Vol.) 594,565

Day's Range $5.14 - $5.51

52-Week Range $2.57 - $7.00

Dividend & Yield N/A (N/A)

CRMD Stock Predictions, Articles, and Cormedix Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jun 29, 2023

We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!

7 Small-Cap Biotech Stocks with Massive Potential

By Josh Enomoto, InvestorPlace Contributor Apr 27, 2023

Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.

7 Biotech Stocks With Huge Return Potential for Long-Term Investors

By Josh Enomoto, InvestorPlace Contributor Apr 26, 2023

Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Aug 9, 2022

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Nov 12, 2021

Good morning! We're kicking off the final day of the trading week with an overview of the biggest pre-market stock movers for Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Nov 1, 2021

Welcome back, investor! We're starting off the trading week with a breakdown of the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on

By William White, InvestorPlace Writer May 14, 2021

We're getting you ready for the last day of trading this week with a look at the biggest pre-market stock movers for Friday!

7 A-Rated Stocks Under $10

By Louis Navellier, Editor, Growth Investor Jul 31, 2019

Small-cap stocks are in great shape here and seven are among the best of the bunch. Here's what you should know about each.

CenturyLink Inc (CTL), Tripadvisor Inc (TRIP) Lead 17 Notable Investor Filings

By Fintel May 9, 2017

CenturyLink (CTL), Gigamon (GIMO) and TripAdvisor (TRIP) are among the more notable investor filings out recently.

Avis Budget Group Inc. (CAR) Leads 8 Notable Investor Filings

By Fintel May 4, 2017

13G and 13D filings are windows into recent activist investor activity. We look at Avis Budget Group Inc. (CAR) and 7 others

CorMedix (CRMD) Q1 2024 Earnings Call Transcript

From The Motley Fool May 9, 2024

CRMD earnings call for the period ending March 31, 2024.

CorMedix (CRMD) Q4 2023 Earnings Call Transcript

From The Motley Fool Mar 12, 2024

CRMD earnings call for the period ending December 31, 2023.

CorMedix collaborates with The Leapfrog Group (NASDAQ:CRMD)

From Seeking Alpha Dec 4, 2023

Biopharmaceutical company CorMedix partners with The Leapfrog Group to advance patient safety initiatives and promote shared accountability.

CorMedix stock jumps on FDA nod for DefenCath (NASDAQ:CRMD)

From Seeking Alpha Nov 15, 2023

The FDA approval of CorMedix's (CRMD) DefenCath to lower infection risk in kidney disease patients on hemodialysis leads to a 35% surge in company shares. Read more here.

CorMedix (CRMD) Q3 2023 Earnings Call Transcript

From The Motley Fool Nov 15, 2023

CRMD earnings call for the period ending September 30, 2023.

CorMedix CEO buys shares worth $37.1k - filing (NASDAQ:CRMD)

From Seeking Alpha Sep 11, 2023

CorMedix (CRMD) CEO Joseph Todisco disclosed in an SEC filing on Friday a purchase of 10,000 shares of the company at $3.71 per share, worth about $37,100.SEC...

ADVERTISEMENT